Congress Park Capital LLC Takes $275,000 Position in Humana Inc. (NYSE:HUM)

Congress Park Capital LLC acquired a new position in Humana Inc. (NYSE:HUMFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 600 shares of the insurance provider’s stock, valued at approximately $275,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Norges Bank purchased a new stake in shares of Humana during the fourth quarter worth about $690,516,000. Starboard Value LP acquired a new stake in Humana in the 1st quarter worth approximately $421,332,000. Ameriprise Financial Inc. grew its position in Humana by 35.9% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock worth $741,409,000 after purchasing an additional 402,559 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in Humana during the 1st quarter valued at approximately $151,766,000. Finally, Morgan Stanley raised its holdings in shares of Humana by 20.8% in the fourth quarter. Morgan Stanley now owns 1,688,442 shares of the insurance provider’s stock worth $864,804,000 after buying an additional 290,865 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on HUM. TheStreet lowered Humana from a “b” rating to a “c+” rating in a research note on Monday, January 8th. Oppenheimer reaffirmed an “outperform” rating and set a $630.00 target price on shares of Humana in a report on Wednesday, January 17th. Raymond James began coverage on Humana in a research report on Friday, March 22nd. They issued a “market perform” rating on the stock. Mizuho decreased their price objective on shares of Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, January 26th. Finally, Stephens dropped their price objective on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a report on Friday, January 26th. Ten equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $494.00.

Get Our Latest Research Report on Humana

Humana Trading Down 0.8 %

Shares of Humana stock opened at $346.72 on Monday. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. Humana Inc. has a twelve month low of $334.54 and a twelve month high of $541.21. The firm has a market capitalization of $41.83 billion, a PE ratio of 17.49, a P/E/G ratio of 2.03 and a beta of 0.45. The firm’s 50-day moving average price is $360.02 and its 200 day moving average price is $440.94.

Humana (NYSE:HUMGet Free Report) last released its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.87). The firm had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a net margin of 2.34% and a return on equity of 19.44%. The business’s revenue was up 17.9% compared to the same quarter last year. During the same quarter last year, the business earned $1.62 EPS. On average, sell-side analysts predict that Humana Inc. will post 16.04 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date is Wednesday, March 27th. Humana’s payout ratio is 17.86%.

Insider Activity

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the purchase, the director now owns 2,578 shares in the company, valued at $946,358.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.29% of the company’s stock.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with's FREE daily email newsletter.